BIOE

Bio Essence Corporation

USD

Set alert

Price alert · BIOE

All alert types
0.47 USD +0.03 +6.82%
As of Oct 30, 2026
0.40 Day range 0.44
0.051 52-week range 0.517
YTD
+683.33%
1 year
+581.16%
Open
0.40
Prev close
0.44
Mkt cap
25.29M
Vol
3.50K
Avg vol
3.62K
EPS
0.03
P/E
15.67
More statistics
Low
0.40
High
0.44

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for BIOE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

5.25 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 4
  • P/B 1

Valuation

P/E 2.5×
FY 2017: -8.3×FY 2018: -11.0×FY 2019: -9.6×FY 2020: -27.8×FY 2021: -25.5×FY 2022: -22.4×FY 2023: -22.9×FY 2024: -7.0×FY 2025: 2.5×
FY 2017 5y median -22.4× FY 2025
P/S 1.2×
FY 2017: 10.9×FY 2018: 16.3×FY 2019: 19.9×FY 2020: 17.2×FY 2021: 18.6×FY 2022: 29.2×FY 2023: 33.2×FY 2024: 28.3×FY 2025: 1.2×
FY 2017 5y median 28.3× FY 2025
P/B -1.1×
FY 2017: 9.6×FY 2018: 94.8×FY 2019: -15.1×FY 2020: -9.3×FY 2021: -6.8×FY 2022: -5.6×FY 2023: -11.0×FY 2024: -3.1×FY 2025: -1.1×
FY 2017 5y median -5.6× FY 2025
P/FCF 1.5×
FY 2017: -6.6×FY 2018: -17.3×FY 2019: -17.8×FY 2020: -22.3×FY 2021: -11.7×FY 2022: -25.7×FY 2023: -17.8×FY 2024: 14.7×FY 2025: 1.5×
FY 2017 5y median -11.7× FY 2025
EV/EBITDA 4.3×
FY 2017: -8.1×FY 2018: -11.1×FY 2019: -11.2×FY 2020: -37.6×FY 2021: -36.5×FY 2022: -45.8×FY 2023: -28.5×FY 2024: -7.6×FY 2025: 4.3×
FY 2017 5y median -28.5× FY 2025
EV/Sales 2.0×
FY 2017: 10.4×FY 2018: 16.4×FY 2019: 22.6×FY 2020: 20.3×FY 2021: 23.0×FY 2022: 36.6×FY 2023: 39.6×FY 2024: 36.6×FY 2025: 2.0×
FY 2017 5y median 36.6× FY 2025
FCF Yield 68.8%
FY 2017: -15.0%FY 2018: -5.8%FY 2019: -5.6%FY 2020: -4.5%FY 2021: -8.6%FY 2022: -3.9%FY 2023: -5.6%FY 2024: 6.8%FY 2025: 68.8%
FY 2017 5y median -3.9% FY 2025

Profitability

Gross Margin 75.3%
FY 2017: 29.0%FY 2018: 36.7%FY 2019: 20.8%FY 2020: 23.7%FY 2021: 33.6%FY 2022: 52.8%FY 2023: 50.3%FY 2024: 67.0%FY 2025: 75.3%
FY 2017 5y median 52.8% FY 2025
Operating Margin 47.4%
FY 2017: -128.9%FY 2018: -152.4%FY 2019: -207.9%FY 2020: -86.8%FY 2021: -96.6%FY 2022: -82.2%FY 2023: -143.1%FY 2024: -141.8%FY 2025: 47.4%
FY 2017 5y median -96.6% FY 2025
Net Margin 47.2%
FY 2017: -131.5%FY 2018: -148.2%FY 2019: -206.1%FY 2020: -62.2%FY 2021: -72.9%FY 2022: -130.3%FY 2023: -176.2%FY 2024: -404.0%FY 2025: 47.2%
FY 2017 5y median -130.3% FY 2025
ROE -43.2%
FY 2017: -115.2%FY 2018: -860.9%FY 2019: 156.9%FY 2020: 33.5%FY 2021: 26.7%FY 2022: 25.0%FY 2023: 58.5%FY 2024: 44.1%FY 2025: -43.2%
FY 2017 5y median 26.7% FY 2025
ROIC -176.4%
FY 2017: -112.9%FY 2018: -509.7%FY 2019: -95.9%FY 2020: -59.0%FY 2021: -55.9%FY 2022: -37.0%FY 2023: -43.4%FY 2024: 173.9%FY 2025: -176.4%
FY 2017 5y median -43.4% FY 2025
ROA 212.1%
FY 2017: -93.3%FY 2018: -142.7%FY 2019: -74.2%FY 2020: -32.3%FY 2021: -38.1%FY 2022: -52.3%FY 2023: -36.5%FY 2024: -465.7%FY 2025: 212.1%
FY 2017 5y median -38.1% FY 2025

Growth (YoY)

Revenue 485.8%
FY 2017: 0.0%FY 2018: -26.5%FY 2019: -16.1%FY 2020: 16.0%FY 2021: -7.4%FY 2022: -30.0%FY 2023: -11.3%FY 2024: -41.3%FY 2025: 485.8%
FY 2017 FY 2025
Operating Income 295.9%
FY 2017: 0.0%FY 2018: 13.0%FY 2019: -14.5%FY 2020: 51.5%FY 2021: -3.0%FY 2022: 40.4%FY 2023: -54.4%FY 2024: 41.8%FY 2025: 295.9%
FY 2017 FY 2025
EPS (diluted) 168.6%
FY 2017: 0.0%FY 2018: 24.7%FY 2019: -14.3%FY 2020: 65.3%FY 2021: -8.9%FY 2022: -25.0%FY 2023: 9.0%FY 2024: -54.3%FY 2025: 168.6%
FY 2017 FY 2025
Free Cash Flow 151.6%
FY 2017: 0.0%FY 2018: 57.8%FY 2019: 0.3%FY 2020: 20.0%FY 2021: -91.0%FY 2022: 50.0%FY 2023: -45.6%FY 2024: 160.6%FY 2025: 151.6%
FY 2017 FY 2025

Financial Health

Current Ratio 0.2×
FY 2017: 4.8×FY 2018: 1.0×FY 2019: 0.5×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.3×FY 2024: 0.1×FY 2025: 0.2×
FY 2017 5y median 0.1× FY 2025
Quick Ratio 0.2×
FY 2017: 2.6×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.3×FY 2024: 0.1×FY 2025: 0.2×
FY 2017 5y median 0.1× FY 2025
Debt / Equity -0.8×
FY 2017: 0.0×FY 2018: 0.7×FY 2019: -2.1×FY 2020: -1.7×FY 2021: -1.6×FY 2022: -1.4×FY 2023: -2.1×FY 2024: -0.9×FY 2025: -0.8×
FY 2017 5y median -1.4× FY 2025
Net Debt / EBITDA 1.7×
FY 2017: 0.4×FY 2018: -0.1×FY 2019: -1.4×FY 2020: -5.7×FY 2021: -7.1×FY 2022: -9.3×FY 2023: -4.5×FY 2024: -1.7×FY 2025: 1.7×
FY 2017 5y median -4.5× FY 2025
Interest Coverage 412×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -71.4×FY 2020: -12.6×FY 2021: -17.8×FY 2022: -26.6×FY 2023: -45.5×FY 2024: -213×FY 2025: 412×
FY 2017 5y median -26.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31